Szela Mary T is a director of Prometheus Biosciences Inc.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kura Oncology, Inc.
7 Jun 24
4
TriSalus Life Sciences, Inc.
14 Feb 24
4
TriSalus Life Sciences, Inc.
15 Aug 23
3
TriSalus Life Sciences, Inc.
15 Aug 23
4
Prometheus Biosciences, Inc.
16 Jun 23
4
Omega Therapeutics, Inc.
9 Jun 23
4
Kura Oncology, Inc.
2 Jun 23
4
Prometheus Biosciences, Inc.
19 May 23
4
Kura Oncology, Inc.
23 Jun 22
4
Omega Therapeutics, Inc.
10 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 24 | KURA Kura Oncology | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 21.79 | 26,000 | 566.54 k | 26,000 |
13 Feb 24 | TLSI TriSalus Life Sciences | Common Stock | Grant | Acquire A | No | No | 0 | 84,899 | 0.00 | 364,862 |
13 Feb 24 | TLSI TriSalus Life Sciences | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 9.4 | 288,750 | 2.71 mm | 288,750 |
14 Aug 23 | TLSI TriSalus Life Sciences | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 11.51 | 172,500 | 1.99 mm | 172,500 |
16 Jun 23 | RXDX Prometheus Biosciences | Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,071 | 0.00 | 0 |
16 Jun 23 | RXDX Prometheus Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 29.02 | 20,500 | 594.91 k | 0 |
16 Jun 23 | RXDX Prometheus Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 19 | 40,000 | 760.00 k | 0 |